Clinical trial
Genetic Susceptibility to Factor VIII Inhibitors
NCT00344435 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00344435 |
|---|---|
| Title | Genetic Susceptibility to Factor VIII Inhibitors |
| Official title | Factor VIII Inhibitor Formation: Identifying Predisposing Genetic Factors |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Hemophilia |
| Enrollment | 1,187 |
| Start date | May 24, 2005 |
| Completion | Apr 5, 2016 |
| First posted | Jun 26, 2006 |
| Last update posted | Apr 5, 2018 |
| Countries | Sweden |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: